KKR’s A$14.5B Takeover Bid Of Australia’s Ramsay Health Care Hits A Snag
Talks regarding KKR & Co (NYSE:KKR)-led consortium buying Australian hospital operator Ramsay Health Care Ltd (OTC:RMSYF) (OTC:RMYHY) have hit a snag. The consortium…
8 Analysts Have This to Say About KKR & Co
Within the last quarter, KKR & Co (NYSE:KKR) has observed the following analyst ratings:
Deutsche Bank Maintains Buy on KKR & Co, Raises Price Target to $68
Deutsche Bank analyst Brian Bedell maintains KKR & Co (NYSE:KKR) with a Buy and raises the price target from $65 to $68.
KKR & Co: Q2 Earnings Insights
KKR & Co (NYSE:KKR) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:50 AM.
Here's what investors need to know about the announcement.
Earnings
KKR & Co reported in-line EPS of $0.95 versus an estimate of $0.95.
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell
• Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
KKR & Co Q2 2022 Earnings Conference Call On August 2, 2022 At 10:00 AM ET
KKR & Co (NYSE:KKR) will host a conference call at 10:00 AM ET on August 2, 2022, to discuss Q2 2022 earnings results.
How to Attend KKR & Co (KKR) Conference Call
Follow this link to access the live webcast.
Morgan Stanley Maintains Equal-Weight on KKR & Co, Lowers Price Target to $60
Morgan Stanley analyst Michael Cyprys maintains KKR & Co (NYSE:KKR) with a Equal-Weight and lowers the price target from $72 to $60.